RT Journal Article
SR Electronic
T1 A pan-European study of SARS-CoV-2 variants in wastewater under the EU Sewage Sentinel System
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.06.11.21258756
DO 10.1101/2021.06.11.21258756
A1 Agrawal, Shelesh
A1 Orschler, Laura
A1 Schubert, Selina
A1 Zachmann, Kira
A1 Heijnen, Leo
A1 Tavazzi, Simona
A1 Gawlik, Bernd Manfred
A1 de Graaf, Miranda
A1 Medema, Gertjan
A1 Lackner, Susanne
YR 2021
UL http://medrxiv.org/content/early/2021/06/14/2021.06.11.21258756.abstract
AB Wastewater based surveillance employing qPCR has already shown its utility for monitoring SARS-CoV-2 at community level, and consequently the European Commission has recommended the implementation of an EU Sewage Sentinel System. However, using sequencing for the determination of genomic variants in wastewater is not fully established yet. Therefore, we focused on the sequencing analysis of SARS-CoV-2 RNA in wastewater samples collected across 20 European countries including 54 municipalities. Our results provide unprecedented insight into the abundance and the profile of the mutations associated with the variants of concerns: B.1.1.7, P.1, B.1.351 and B.1.617.2, which were present in various wastewater samples. This study shows that integrating genomic and wastewater-based epidemiology (WBE) can support the identification of variants circulating in a city at community level.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study received no extra funding.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:no approval was necessary.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data is available on NCBI.